187 related articles for article (PubMed ID: 6288532)
1. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
Pabst HW; Langhammer H; Schmid L; Sintermann R
Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
[TBL] [Abstract][Full Text] [Related]
2. Optimizing the performance and interpretation of bone scans.
Muroff LR
Clin Nucl Med; 1981 Oct; 6(10S):P68-76. PubMed ID: 6271444
[No Abstract] [Full Text] [Related]
3. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
Pauwels EK; Heslinga JM; Zwaveling A
Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
[No Abstract] [Full Text] [Related]
4. [Bone-seeking radiopharmaceuticals in evaluating the treatment of skeletal metastases of malignant tumors].
Naumenko AZ; Korsunskiĭ VN
Med Radiol (Mosk); 1984 Mar; 29(3):27-30. PubMed ID: 6321881
[TBL] [Abstract][Full Text] [Related]
5. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
6. [Cancer of the prostate: value of bone scintigraphy. Point of view].
Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
[TBL] [Abstract][Full Text] [Related]
7. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
[TBL] [Abstract][Full Text] [Related]
8. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of skeletal tumors using 113mIn-indifor].
Mechev DS; Siniuta BF
Med Radiol (Mosk); 1988 Jun; 33(6):22-7. PubMed ID: 2838715
[TBL] [Abstract][Full Text] [Related]
10. Nuclear bone imaging in metastatic cancer of the prostate.
Pollen JJ; Gerber K; Ashburn WL; Schmidt JD
Cancer; 1981 Jun; 47(11):2585-94. PubMed ID: 6266636
[No Abstract] [Full Text] [Related]
11. [Scintigraphic evaluation of the efficacy of treatment of cancer of the breast with bone metastases].
Gabuniia RI; Godin VP; Gritsaĭ AA; Kirsanov AG; Aplevich NN
Med Radiol (Mosk); 1989 Apr; 34(4):49-53. PubMed ID: 2540391
[TBL] [Abstract][Full Text] [Related]
12. Serial radionuclide imaging during treatment of patients with diffuse bone metastases from carcinoma of the prostate.
Perkins AC; Hardy JG; Wastie ML; Clifford KM
Eur J Nucl Med; 1982; 7(7):322-3. PubMed ID: 6214398
[No Abstract] [Full Text] [Related]
13. Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.
Levenson RM; Sauerbrunn BJ; Bates HR; Newman RD; Eddy JL; Ihde DC
Radiology; 1983 Feb; 146(2):513-8. PubMed ID: 6294738
[TBL] [Abstract][Full Text] [Related]
14. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.
Roudier MP; Vesselle H; True LD; Higano CS; Ott SM; King SH; Vessella RL
Clin Exp Metastasis; 2003; 20(2):171-80. PubMed ID: 12705638
[TBL] [Abstract][Full Text] [Related]
15. Misleading renal stasis on bone scintigraphy in diffuse symmetrical skeletal metastases of prostatic carcinoma.
Kalin B; Jacobsson H
Rofo; 1987 Oct; 147(4):465-6. PubMed ID: 2825278
[No Abstract] [Full Text] [Related]
16. Technetium-99m DMSA uptake by metastatic carcinoma of the prostate.
Jeghers O; Puttemans N; Urbain D; Ham HR
J Nucl Med; 1986 Jul; 27(7):1223-4. PubMed ID: 3014089
[No Abstract] [Full Text] [Related]
17. Tc-99m DMSA uptake by metastatic carcinoma of the prostate.
Lamki L; Shearer R
J Nucl Med; 1984 Jun; 25(6):733-4. PubMed ID: 6327947
[No Abstract] [Full Text] [Related]
18. Normal technetium 99m diphosphonate bone scintigraphy in skeletal metastases from hepatocellular carcinoma.
Maillefert JF; Tebib J; Quipourt V; Brunotte F; Michiels C; Hillon P; Tavernier C
J Hepatol; 1994 Oct; 21(4):684. PubMed ID: 7814817
[No Abstract] [Full Text] [Related]
19. [The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Morita R; Sone T; Yoneda M; Saito N; Tanaka H; Tomomitsu T; Yanagimoto S; Muranaka A
Kaku Igaku; 1985 Feb; 22(2):169-76. PubMed ID: 3159922
[No Abstract] [Full Text] [Related]
20. [Scintigraphy in primary malignant bone tumors and bone metastases].
Vlakhov N; Mirchev V
Vopr Onkol; 1987; 33(9):102-4. PubMed ID: 2821697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
